Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00034924.xml
Nuklearmedizin 2022; 61(05): 414-415
DOI: 10.1055/a-1809-4570
DOI: 10.1055/a-1809-4570
Case Report
Discrepancy of PSMA PET imaging and bone scan showing limited value of bone scan and CT in evaluation of extent of bone involvement
Diskrepanz zwischen PSMA-PET-Bildgebung und Knochenszintigraphie zeigt eine begrenzte Wertigkeit der Knochenszintigraphie und CT bei der Beurteilung des Ausmaßes der Knochenbeteiligung
Publication History
Received: 01 December 2021
Accepted after revision: 25 March 2022
Article published online:
11 July 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Budd RS, Hodgson GS, Hare WS. et al. The relation of radionuclide uptake by bone to the rate of calcium mineralization. II: Patient studies using 99Tcm-MDP. Br J Radiol 1989; 62: 318-320
- 2 Poeppel. et al. “EANM guideline for radionuclide therapy with radium-223 of metastatic tration-resistant prostate cancer”. European Journal of Nuclear Medicine and Molecular Imaging 2018; 45: 824-845 DOI: 10.1007/s00259-017-3900-4. (PMID: 29234845)
- 3 Bräuer. et al. “Diagnostic value of additional 68Ga-PSMA-PET before 223Ra-dichloride therapy in patients with metastatic prostate carcinoma”. Nuklearmedizin 2017; 56 (01) 14-22 DOI: 10.3413/Nukmed-0846-16-09. (PMID: 28074210)
- 4 Hartrampf. et al. “Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia vera”. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48: 1669-1670
- 5 Kunikowska J, Pełka K. “Myelofibrosis Pattern in 68Ga-PSMA PET/CT of a Patient With Recurrence Prostate Cancer”. Clinical Nuclear Medicine 2022; 47 (02) e182-e183 DOI: 10.1097/RLU.0000000000003838.